Literature DB >> 7795231

Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.

P Aukrust1, A M Svardal, F Müller, B Lunden, R K Berge, P M Ueland, S S Frøland.   

Abstract

We investigated the intracellular glutathione redox status in isolated lymphocyte subpopulations and monocytes in patients with human immunodeficiency virus type 1 (HIV-1) infection and in healthy controls. CD4+ lymphocytes from HIV-1-infected patients were primarily characterized by a substantial increase in oxidized glutathione levels and a considerable decrease in the ratio of reduced to total glutathione, in most cases below 0.5 in patients with symptomatic HIV-1 infection, rather than decreased levels of reduced glutathione. The increase in oxidized glutathione was strongly correlated with low numbers of CD4+ lymphocytes in peripheral blood and impaired stimulated interleukin-2 production and proliferation in peripheral blood mononuclear cells, which is compatible with an immunopathogenic role for these redox disturbances. The HIV-1-infected patients with the most advanced clinical and immunologic disease were also characterized by an increase in levels of reduced glutathione in monocytes, suggesting that the glutathione redox cycle may be differentially regulated in CD4+ lymphocytes and monocytes. We could not confirm previous reports suggesting cysteine deficiency as a major cause of disturbed glutathione homeostasis during HIV-1 infection. The demonstrated glutathione abnormalities were correlated with raised serum levels of tumor necrosis factor alpha. These findings suggest that a therapeutical approach, which can restore the glutathione redox dysbalance in CD4+ lymphocytes and decrease the inflammatory stress, may be worthwhile exploring in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795231

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Adverse drug reactions.

Authors:  M Pirmohamed; A M Breckenridge; N R Kitteringham; B K Park
Journal:  BMJ       Date:  1998-04-25

2.  Novel inhibitory effects of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1 production and propagation.

Authors:  S Kubota; S Shetty; H Zhang; S Kitahara; R J Pomerantz
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 3.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

4.  Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.

Authors:  Thangavel Samikkannu; Kurapati V K Rao; Sudhessh Pilakka Kanthikeel; Venkata Subba Rao Atluri; Marisela Agudelo; Upal Roy; Madhavan P N Nair
Journal:  Free Radic Biol Med       Date:  2014-01-27       Impact factor: 7.376

5.  Reactive Oxygen Species in HIV Infection.

Authors:  Jennifer Couret; Theresa L Chang
Journal:  EC Microbiol       Date:  2016-10-18

6.  A glutathione reductase mutant of yeast accumulates high levels of oxidized glutathione and requires thioredoxin for growth.

Authors:  E G Muller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

7.  HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.

Authors:  I Stefanová; M W Saville; C Peters; F R Cleghorn; D Schwartz; D J Venzon; K J Weinhold; N Jack; C Bartholomew; W A Blattner; R Yarchoan; J B Bolen; I D Horak
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose.

Authors:  R Rubinstein; A M Genaro; A Motta; G Cremaschi; M R Wald
Journal:  Clin Exp Immunol       Date:  2008-09-05       Impact factor: 4.330

9.  The initial step in human immunodeficiency virus type 1 GagProPol processing can be regulated by reversible oxidation.

Authors:  Sarah I Daniels; David A Davis; Erin E Soule; Stephen J Stahl; Irene R Tebbs; Paul Wingfield; Robert Yarchoan
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

10.  Decreased IL-7 responsiveness is related to oxidative stress in HIV disease.

Authors:  Magdalina Kalinowska; Douglas A Bazdar; Michael M Lederman; Nicholas Funderburg; Scott F Sieg
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.